STOCK TITAN

Synergy CHC (SNYR) CFO gets 150,000-share option repriced to $0.21

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Synergy CHC Corp. Chief Financial Officer Jaime Fickett reported a restructuring of an existing stock option award. An original option covering 150,000 shares of common stock with a $2.38 exercise price was deemed canceled for Section 16 purposes, and a new option for 150,000 shares was granted with a reduced exercise price of $0.21 per share.

According to the footnotes, this reduction in exercise price is treated as a material modification, with the new option keeping the same vesting schedule and a five-year term from the original September 18, 2025 grant date. One-third of the option vests on the first anniversary of that date, and the remaining two-thirds vest in equal monthly installments over the following 24 months, subject to continued service.

Positive

  • None.

Negative

  • None.
Insider Fickett Jaime
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 150,000 $0.00 --
Disposition Stock Option (right to buy) 150,000 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 150,000 shares (Direct, null)
Footnotes (1)
  1. One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company. The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.
Options canceled 150,000 options Original option deemed canceled for Section 16 purposes
New options granted 150,000 options Replacement grant covering common stock
Original exercise price $2.38 per share Exercise price on original option
New exercise price $0.21 per share Exercise price on replacement option
Vesting schedule 1/3 at first anniversary, 2/3 over 24 months From original September 18, 2025 grant date
Option term Five years Expires on five-year anniversary of September 18, 2025
material modification financial
"The reduction in the exercise price of the Original Option constitutes a material modification"
exercise price financial
"The reduction in the exercise price of the Original Option constitutes a material modification"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Section 16 regulatory
"deemed, for purposes of Section 16, to involve a cancellation of the Original Option"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
grant date financial
"as if it had been granted on the Original Grant Date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vests in equal monthly installments financial
"the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fickett Jaime

(Last)(First)(Middle)
C/O SYNERGY CHC CORP.
770 ROOSEVELT TRAIL STE 8 #1016

(Street)
N. WINDHAM MAINE 04062

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Synergy CHC Corp. [ SNYR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$0.2106/29/2026A150,000 (1)09/18/2030Common Stock, par value $0.00001 per share150,000(2)150,000D
Stock Option (right to buy)$2.3806/29/2026D150,000 (1)09/18/2030Common Stock, par value $0.00001 per share150,000(2)0D
Explanation of Responses:
1. One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.
2. The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Synergy CHC Corp. (SNYR) report for its CFO?

Synergy CHC Corp. reported that CFO Jaime Fickett restructured an existing stock option. A prior option was deemed canceled and replaced with a new 150,000-share option at a lower exercise price, while keeping the same vesting schedule and overall structure under Section 16 rules.

How many Synergy CHC (SNYR) shares are covered by the CFO’s new stock option?

The new stock option granted to CFO Jaime Fickett covers 150,000 shares of Synergy CHC common stock. This matches the share count of the original option, reflecting a repricing rather than a change in the number of underlying shares under the award.

What is the new exercise price of the CFO’s Synergy CHC (SNYR) stock option?

The new option for CFO Jaime Fickett has an exercise price of $0.21 per share. The original option had a $2.38 exercise price, and the reduction is treated as a material modification and a new grant under Section 16 reporting rules.

How does the vesting schedule work for the Synergy CHC (SNYR) CFO option grant?

One-third of the option vests on the first anniversary of September 18, 2025, the original grant date. The remaining two-thirds vest in equal monthly installments over the following 24 months, and all vesting is conditioned on the CFO’s continued service with the company.

Why is the Synergy CHC (SNYR) CFO option repricing treated as a cancellation and new grant?

The filing states the reduction in exercise price is a material modification. For Section 16 purposes, this is deemed a cancellation of the original option and the grant of a new option, even though the share count and vesting schedule remain the same.

When does the Synergy CHC (SNYR) CFO stock option expire?

The new option expires on the five-year anniversary of the original September 18, 2025 grant date. The filing explains that, despite the repricing, the option term is measured from that original grant date, consistent with how the modification is treated under Section 16.